title: Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat.
abstract: We have studied the ability of the vigilance-promoting drug modafinil to counteract the ischemic lesion produced by a unilateral microinjection of endothelin-1 (ET-1) in the neostriatum of the rat using a combined morphometrical, biochemical, cardiovascular and behavioral analysis. ET-1 was injected unilaterally into the neostriatum. The ET-1-induced lesion volume, which was determined by a computer-assisted morphometrical analysis, was reduced by the 7-day modafinil treatment (10, 30, and 100 mg/kg i.p.) in a dose-related way. Modafinil also produced a dose-related counteraction of the ET-1-induced increase of perfusate lactate levels, as determined by intrastriatal microdialysis without affecting the ET-1 induced reduction of striatal blood flow, as determined by laser-Doppler flowmetry. The ipsilateral rotational behavior induced by apomorphine in the ET-1-lesioned rats was reduced dose-dependently by modafinil treatment. Thus, morphological, neurochemical, and behavioral evidence that the putative ischemic striatal injury induced by microinjection of ET-1 in the rat neostriatum is counteracted in a dose-dependent way by modafinil treatment has been obtained. The mechanism does not appear to involve an increase in striatal blood flow. It is instead speculated that its powerful preventive action in striatal ischemic injury may be related to a reduced anaerobic metabolism.
authors.affiliation: Department of Histology and Neurobiology, Karolinska Institute, Stockholm, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Ueki
authors.forename: L
authors.initials: L
authors.lastname: Rosén
authors.forename: B
authors.initials: B
authors.lastname: Andbjer
authors.forename: L F
authors.initials: LF
authors.lastname: Agnati
authors.forename: A
authors.initials: A
authors.lastname: Hallström
authors.forename: M
authors.initials: M
authors.lastname: Goiny
authors.forename: S
authors.initials: S
authors.lastname: Tanganelli
authors.forename: U
authors.initials: U
authors.lastname: Ungerstedt
authors.forename: K
authors.initials: K
authors.lastname: Fuxe
mesh_terms: D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001143:Arousal / Q000187:drug effects*; D001559:Benzhydryl Compounds / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002545:Brain Ischemia / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D016232:Endothelins / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics / Q000633:toxicity; D006439:Hemodynamics / Q000187:drug effects; D007267:Injections; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D017551:Microdialysis; D000077408:Modafinil; D017072:Neostriatum / Q000098:blood supply* / Q000187:drug effects / Q000473:pathology; D011773:Pyruvates / Q000097:blood; D019289:Pyruvic Acid; D051381:Rats; D017207:Rats, Sprague-Dawley; D013238:Stereotaxic Techniques; D013239:Stereotyped Behavior / Q000187:drug effects
chemical_list: D001559:Benzhydryl Compounds; D016232:Endothelins; D007773:Lactates; D011773:Pyruvates; D019344:Lactic Acid; D019289:Pyruvic Acid; D000661:Amphetamine; D000077408:Modafinil